Generation of glucocorticoid-resistant SARS-CoV-2 T cells for adoptive cell therapy

Adoptive cell therapy with virus-specific T cells has been used successfully to treat life-threatening viral infections, supporting application of this approach to coronavirus disease 2019 (COVID-19). We expand severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) T cells from the peripheral...

Descripción completa

Detalles Bibliográficos
Autores principales: Basar, Rafet, Uprety, Nadima, Ensley, Emily, Daher, May, Klein, Kimberly, Martinez, Fernando, Aung, Fleur, Shanley, Mayra, Hu, Bingqian, Gokdemir, Elif, Nunez Cortes, Ana Karen, Mendt, Mayela, Reyes Silva, Francia, Acharya, Sunil, Laskowski, Tamara, Muniz-Feliciano, Luis, Banerjee, Pinaki P., Li, Ye, Li, Sufang, Melo Garcia, Luciana, Lin, Paul, Shaim, Hila, Yates, Sean G., Marin, David, Kaur, Indreshpal, Rao, Sheetal, Mak, Duncan, Lin, Angelique, Miao, Qi, Dou, Jinzhuang, Chen, Ken, Champlin, Richard E., Shpall, Elizabeth J., Rezvani, Katayoun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260499/
https://www.ncbi.nlm.nih.gov/pubmed/34270918
http://dx.doi.org/10.1016/j.celrep.2021.109432

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260499/
https://www.ncbi.nlm.nih.gov/pubmed/34270918
http://dx.doi.org/10.1016/j.celrep.2021.109432

Ejemplares similares